Skip Navigation
NIAID > Health & Research Topics > Vaccines

Vaccines

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • Pin it
  • submit to Google +

Vaccine Research

Vaccines provide safe, cost-effective, and efficient means of preventing illness, disability, and death from infectious diseases. NIAID conducts and supports research on new and improved vaccines and is a worldwide leader in the basic immunology research that underpins all vaccine research and development.

NIAID Research

Highlights

Chinnaswamy Jagannath, Ph.D. Woman giving injection to child
 

TB Vaccine Development: Engineered Autophagy Boosts BCG Protective Immunity May Result in New Strategies for TB Vaccine Development

Jordan Report: Accelerated Development of Vaccines 2012

Videocast: HHS Science Seminar for Media—Advances in Influenza Vaccine Technologies

NIAID Network of Vaccine and Treatment Evaluation Units (VTEUs)

NIAID Lab Developing Intranasal RSV Vaccines

NIAID Scientists Use Reverse Genetics to Develop Potential Dengue Vaccine

Flu Shots No More? NIAID Grantees Use New Skin Patches to Deliver Flu Vaccine in Mice

Program Announcement

Research to Advance Vaccine Safety (R01 and R21)

News and Events

Media Availability: NIH Scientists Identify Protective Role for Antibodies in Ebola Vaccine Study—Jan. 14, 2013

Leadership Transition at the NIAID Vaccine Research Center—Nov. 14, 2012

NIH Awards $7.8 Million for Innovative HIV Vaccine Approaches—Aug. 21, 2012

Media Availability: NIH Study Suggests Potential Hurdle to Universal Flu Vaccine Development May Be Overcome—Aug. 15, 2012

All vaccine news and events

News from NIAID-Supported Institutions

Last Updated January 14, 2013